CXCL10 and neoplasm: Conversely, in the presence of a systemic CXCL10 gradient, OS tumors that produce chemoattractants fail to recruit adequate immunity, compromising this potent immune-recruiting system and tipping the balance toward unchecked tumor growth and overt metastasis.